Fresh analysis suggests that people who discontinue popular slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass far faster than those who stop traditional lifestyle programs.
Published data in a major health publication points out that while overweight people can lose substantial amounts of their total mass while undergoing treatment, the weight is regained at an average rate of nearly a kilo each month once they quit.
"People purchasing such medications should be cognizant of the potential of rapid rebound weight gain when the treatment is stopped," cautioned expert Dr. Susan Jebb.
Such speed of recovery means a reversion to original mass in about 18 months.
Comparing Therapies
The study, which reviewed dozens of studies involving over 9,000 of patients, compared the outcomes of these new drugs with conventional dieting.
The team point out that individuals who shed pounds through lifestyle changes alone generally experience a slower creep back—around 100 grams monthly—once they finish.
Explaining the Quick Rebound
Experts believe the mode of action of the jabs explains the accelerated rebound.
These medications copy a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Sustained high doses of GLP-1 concentrations several times higher than the body's typical production might result in the system to produce less of its endogenous GLP-1, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this medication results in appetite is uncontrolled, making overeating far more likely."
An Ongoing Disease?
Medical guidelines recommend the injections for individuals with obesity-related medical conditions, accompanied by prescribed lifestyle changes.
Many experts contend that, considering the high risk of weight regain, the treatment should be considered life-long.
This view is supported by drug manufacturers, who say that the results "underscore the chronic character of obesity," akin to managing conditions like hypertension.
Patient Testimonies
Users who have discontinued the jabs describe a powerful return of appetite.
"I experienced a trigger activating and I was suddenly starving," described one woman.
The struggle is exacerbated if users have not established lasting lifestyle or habit changes during treatment.
Widespread Use
Figures suggest that millions of adults in the UK have tried these injections in the past year, with interest remaining high.
- Adoption is higher among women compared to males.
- The middle-aged demographic shows the highest level of interest.
- Many obtain the drugs through private healthcare rather than public health services.
In conclusion, experts emphasize that while these medications are effective tools for weight loss, they are not a standalone fix and long-term success hinges on integrated lifestyle support.
